Vicplas International (SGX:569) Cash And Cash Equivalents : S$4.5 Mil (As of Jan. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Vicplas International Cash And Cash Equivalents?

Vicplas International's quarterly cash and cash equivalents increased from Jan. 2023 (S$6.66 Mil) to Jul. 2023 (S$8.57 Mil) but then stayed the same from Jul. 2023 (S$8.57 Mil) to Jan. 2024 (S$4.46 Mil).

Vicplas International's annual cash and cash equivalents declined from Jul. 2021 (S$9.87 Mil) to Jul. 2022 (S$8.89 Mil) and declined from Jul. 2022 (S$8.89 Mil) to Jul. 2023 (S$8.57 Mil).

Vicplas International Cash And Cash Equivalents Historical Data

The historical data trend for Vicplas International's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicplas International Cash And Cash Equivalents Chart

Vicplas International Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Cash And Cash Equivalents

Get a 7-Day Free Trial

4.11

4.48

9.87

8.89

8.57

Vicplas International Semi-Annual Data
	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23	Jan24
Cash And Cash Equivalents	Get a 7-Day Free Trial															5.53	8.89	6.66	8.57	4.46

Vicplas International Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Vicplas International (SGX:569) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Vicplas International Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Vicplas International's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Vicplas International (SGX:569) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vicplas International Ltd (SGX:569) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

35 Joo Koon Circle, Singapore, SGP, 629110

Website

https://www.vicplas.com

Vicplas International Ltd is an investment holding company. The company is organized into two main business activities: the Pipes and Pipe Fitting segment and the Medical Devices segment, which is the key revenue driver. Pipes and Pipe Fittings segment engages in the manufacturing and distribution of plastic building products, including uPVC pipes and pipe fittings and electrical conduits. The Medical device segment is involved in the research, design, development, and manufacture of medical devices. The company generates majority of its revenue from medical devices. The company does its sales through geographical segments that include Singapore, Malaysia, China, and the United Kingdom, of which the majority of the revenue comes from Singapore.

Vicplas International (SGX:569) Headlines

No Headlines